-
Approval of new medicines in 2022 sets Ferring on course for future growth and diversification
in PRESS RELEASE 2023 onApproval of new medicines in 2022 sets Ferring on course for future…
00 -
Ferring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer
in PRESS RELEASE 2023 onFerring Pharmaceuticals appoints Pierre-Yves Berclaz as Executive Vice President, Chief Medical Officer…
PRESS RELEASE 2023
PRESS RELEASE 2023